Marc Teunis
Overview
Explore the profile of Marc Teunis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
59
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Teunis M, Luechtefeld T, Hartung T
Front Toxicol
. 2025 Feb;
7:1568453.
PMID: 40012887
No abstract available.
2.
Staumont B, Ladeira L, Gamba A, Heusinkveld H, Piersma A, Fritsche E, et al.
ALTEX
. 2025 Feb;
PMID: 39918919
Chemical safety assessment still heavily relies on animal testing, presenting ethical dilemmas and limited human predictive value. New approach methodologies (NAMs), including in vitro and in silico techniques, offer alternative...
3.
Diemar M, Krul C, Teunis M, Busquet F, Kandarova H, Zajac J, et al.
Altern Lab Anim
. 2024 Dec;
53(1):42-61.
PMID: 39694026
The first ONTOX Hackathon of the EU Horizon 2020-funded ONTOX project was held on 21-23 April 2024 in Utrecht, The Netherlands (https://ontox-project.eu/hackathon/). This participatory event aimed to collectively advance innovation...
4.
Kienhuis A, Krul C, van Engelen J, Evelo C, Hessel E, Hoekman J, et al.
ALTEX
. 2024 Oct;
42(1):111-120.
PMID: 39396389
The Virtual Human Platform for Safety Assessment (VHP4Safety) project aims to build a virtual human platform (VHP) to protect human health and revolutionize the safety assessment of chemicals and pharmaceuticals...
5.
Verwoerd M, Wittink H, Maissan F, Teunis M, van Kuijk S, Smeets R
BMJ Open
. 2024 Aug;
14(8):e086683.
PMID: 39182932
Objective: To develop and internally validate a prognostic model to predict chronic pain after a new episode of acute or subacute non-specific idiopathic, non-traumatic neck pain in patients presenting to...
6.
Corradi M, Luechtefeld T, de Haan A, Pieters R, Freedman J, Vanhaecke T, et al.
Front Toxicol
. 2024 May;
6:1393662.
PMID: 38800806
To study the ways in which compounds can induce adverse effects, toxicologists have been constructing Adverse Outcome Pathways (AOPs). An AOP can be considered as a pragmatic tool to capture...
7.
Verhoeven A, van Ertvelde J, Boeckmans J, Gatzios A, Jover R, Lindeman B, et al.
Toxicology
. 2024 Apr;
505:153814.
PMID: 38677583
The field of chemical toxicity testing is undergoing a transition to overcome the limitations of in vivo experiments. This evolution involves implementing innovative non-animal approaches to improve predictability and provide...
8.
Diemar M, Vinken M, Teunis M, Krul C, Busquet F, Zajac J, et al.
Altern Lab Anim
. 2024 Jan;
52(2):117-131.
PMID: 38235727
The first Stakeholder Network Meeting of the EU Horizon 2020-funded ONTOX project was held on 13-14 March 2023, in Brussels, Belgium. The discussion centred around identifying specific challenges, barriers and...
9.
Maertens A, Antignac E, Benfenati E, Bloch D, Fritsche E, Hoffmann S, et al.
ALTEX
. 2024 Jan;
41(2):273-281.
PMID: 38215352
Both because of the shortcomings of existing risk assessment methodologies, as well as newly available tools to predict hazard and risk with machine learning approaches, there has been an emerging...
10.
Knipping K, Kartaram S, Teunis M, Zuithoff N, Buurman N, MRabet L, et al.
PLoS One
. 2023 Nov;
18(11):e0291297.
PMID: 37992002
Aim: To investigate the effects of exercise on salivary concentrations of inflammatory markers by analyzing a panel of 25 inflammatory markers in subjects who had participated in bicycle ergometer tests...